Invasive pulmonary aspergillosis

MP Ledoux, B Guffroy, Y Nivoix… - … in respiratory and …, 2020 - thieme-connect.com
Invasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most
common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ …

[HTML][HTML] Antifungal prophylaxis and pre-emptive therapy: When and how?

R Sprute, JA Nacov, D Neofytos, M Oliverio… - Molecular aspects of …, 2023 - Elsevier
The growing pool of critically ill or immunocompromised patients leads to a constant
increase of life-threatening invasive infections by fungi such as Aspergillus spp., Candida …

Invasive aspergillosis in solid‐organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

S Husain, JF Camargo - Clinical transplantation, 2019 - Wiley Online Library
These updated AST‐IDCOP guidelines provide information on epidemiology, diagnosis, and
management of Aspergillus after organ transplantation. Aspergillus is the most common …

Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population‐based cohort study

SM Hosseini‐Moghaddam… - Transplant Infectious …, 2020 - Wiley Online Library
Background Invasive fungal infection (IFI) in solid organ transplant (SOT) recipients is
associated with significant morbidity and mortality. The long‐term probability of post …

Bronchopulmonary penetration of isavuconazole in lung transplant recipients

AF Caballero-Bermejo… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Isavuconazole's (ISA) pharmacokinetics was studied among lung transplant recipients to
evaluate its bronchopulmonary penetration. This study included 13 patients and showed …

[HTML][HTML] Fungal infections in lung transplantation

P Samanta, CJ Clancy, MH Nguyen - Journal of Thoracic Disease, 2021 - ncbi.nlm.nih.gov
Lung transplant is a potential life-saving procedure for chronic lung diseases. Lung
transplant recipients (LTRs) are at the greatest risk for invasive fungal infections (IFIs) …

Risk factors of invasive fungal infections in lung transplant recipients: a systematic review and meta-analysis

P Phoompoung, APC Villalobos, S Jain… - The Journal of Heart and …, 2022 - Elsevier
Background: Invasive fungal infection (IFI) remains a common complication after lung
transplantation, causing significant morbidity and mortality. We have attempted to quantify …

Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease

SP Hogea, E Tudorache, C Pescaru… - Expert Review of …, 2020 - Taylor & Francis
Introduction Bronchoalveolar lavage (BAL), a noninvasive, well-tolerated procedure is an
important diagnostic tool that can facilitate the diagnosis of various lung diseases. This …

Statin use may be associated with a lower risk of invasive aspergillosis in lung transplant recipients

APC Villalobos, F Foroutan, S Davoudi… - Clinical Infectious …, 2023 - academic.oup.com
Background Statins are competitive inhibitors of 3-hydroxy-3methylglutaryl coenzyme A
reductase (HMG-CoA reductase) that catalyses HMG-CoA conversion to mevalonate, a …

Update on therapeutic approaches for invasive fungal infections in adults

CA Boutin, ML Luong - Therapeutic Advances in Infectious …, 2024 - journals.sagepub.com
Invasive fungal infections are increasingly encountered with the expansion of iatrogenic
immunosuppression, including not only solid organ and hematopoietic stem cell transplant …